Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular growth markets insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Many American healthtech companies would have more success in emerging markets

Image

06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]

Read More

Korean medical institutions continue their global expansion

Image

06-Apr-17 Korea's medical institutions expanded their businesses into 20 countries during 2016, according to a report by the Ministry of Health & Welfare. During 2016, Korean medical institutions continued their spread of the medicalss "Korean wave”, entering countries including China, the USA, Vietnam, Kazakhstan, and the UAE as well as many others, three more countries than in 2015. [image: Business Korea]

Read More

Korean company SK Holdings C&C begins providing AI medical treatment

Image

06-Apr-17 Korean company SK Holdings C&C has opened an AI cancer medical centre providing medical treatment through IBM's Watson for Oncology with Kunyang University Hospital. The AI service provided by Watson for oncology allows patients to receive cancer treatments at international standards proven around the world, without leaving their home. [image: Business Korea]

Read More

Takeda to initiate large scale dengue vaccine trial in Asia and Latin America

Image

06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]

Read More

Zuellig Pharma invests in first innovation centre in Singapore

Image

05-Apr-17 Singapore based Zuellig Pharma has launched Zuellig Health Solutions innovation centre, in Singapore and plans to invest over USD35 mn in the next five years. On why it chose Singapore for its new venture, CEO John Davison said: "We see many of our clients in the pharmaceutical and consumer health sector (such as) GlaxoSmithKline and AstraZeneca here in Singapore." [image: Zuellig Pharma]

Read More
Share

 


0111 Banner square pre launch 250x250